Allan Frank Fischer Petersen
Directeur/Bestuurslid bij Biogen (Denmark) A/S
Profiel
Allan Frank Fischer Petersen is currently a Director at Biogen (Denmark).
A since 2012.
He previously worked as the Chief Executive Officer at FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS.
Actieve functies van Allan Frank Fischer Petersen
| Bedrijven | Functie | Begin |
|---|---|---|
Biogen (Denmark) A/S
 Biogen (Denmark) A/S BiotechnologyHealth Technology Biogen (Denmark) A/S manufactures therapies and pharmaceuticals. The company is headquartered in Glostrup, Denmark. | Directeur/Bestuurslid | 10-04-2012 |
Eerdere bekende functies van Allan Frank Fischer Petersen
| Bedrijven | Functie | Einde |
|---|---|---|
Biogen (Denmark) New Manufacturing ApS
 Biogen (Denmark) New Manufacturing ApS BiotechnologyHealth Technology Biogen (Denmark) New Manufacturing ApS engages in neuroscience. The firm offers therapies for multiple sclerosis, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, as well as less common diseases such as spinal muscle atrophy, and progressive supranuclear palsy. The company was founded on July 1, 2008 and is headquartered in Hillerod, Denmark. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Biogen (Denmark) A/S
Biogen (Denmark) A/S BiotechnologyHealth Technology Biogen (Denmark) A/S manufactures therapies and pharmaceuticals. The company is headquartered in Glostrup, Denmark. | Health Technology |
Biogen (Denmark) New Manufacturing ApS
Biogen (Denmark) New Manufacturing ApS BiotechnologyHealth Technology Biogen (Denmark) New Manufacturing ApS engages in neuroscience. The firm offers therapies for multiple sclerosis, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, as well as less common diseases such as spinal muscle atrophy, and progressive supranuclear palsy. The company was founded on July 1, 2008 and is headquartered in Hillerod, Denmark. | Health Technology |
